Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
Trackers› Clinical trials› Bankstown
Clinical trial register · Australia

Clinical Trials in Bankstown, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Australia and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 3343 matching records held by the registry are in this view. Synced 15 Oct 2026, 03:18 UTC
3343
Studies in scope
all four open statuses
1804
Recruiting now
open to new participants
765
Lead sponsors
across recruiting studies
Top sites
Melbourne 1096 Adelaide 565 Sydney 508 Westmead 416 Clayton 407
Narrow the registerReset
Recruitment status
Phase
Site location
Melbourne1096 Adelaide565 Sydney508 Westmead416 Clayton407
All 401 locations
Target enrolment
to

Trials with a site in Bankstown

19 of 3343 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Australia
Start
Recruiting
Taiho Oncology, Inc.
Phase 3
360
Bankstown, St Leonards, Subiaco
2025-12-22
Recruiting
ROADMAP Clinical Trial
NCT06771050Prosthetic Joint Infections of Hip, Prosthetic Joint Infections of Knee, Large Joint Prosthetic Joint Infections
University of Newcastle, Australia
Phase 4
2,500
Garran, Bankstown, Blacktown, Campbelltown, Camperdown, Caringbah, Gateshead, Kingswood
2025-03-24
Recruiting
Loxo Oncology, Inc.
Phase 2
249
Adelaide, Bankstown, Box Hill, Coffs Harbour, Hobart, Kurralta Park, Traralgon, Waratah
2025-01-03
Active, closed
Coherus Oncology, Inc.
Phase 2
72
Herston, Bankstown, Melbourne, Darlinghurst, Nedlands
2024-12-20
Active, closed
AbbVie
Phase 2
156
Bankstown, Elizabeth Vale, Woodville South, Fitzroy Melbourne, Murdoch
2024-03-23
Active, closed
AstraZeneca
Phase 3
5,511
Bankstown, Bendigo, Bowral, Brighton, Clayton, Coffs Harbour, Fitzroy, Frankston
2023-10-05
Recruiting
A Study of Zipalertinib in Patients With Advanced Non-Small Cell Lung Cancer With Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertions or Other Uncommon Mutation.
NCT05967689Advanced or Metastatic NSCLC Harboring Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertion (ex20ins) Mutations
Taiho Oncology, Inc.
Phase 2
220
Bankstown, Saint Leonards, Joondalup
2023-07-31
Active, closed
OncoC4, Inc.
Phase 3
630
Bankstown, Newstead, Adelaide, St Albans
2023-06-28
Active, closed
Study to Evaluate Adverse Events and Change in Disease Activity in Adult Participants With B-Cell Malignancies Receiving Oral ABBV-525 Tablets
NCT05618028Diffuse Large B-Cell Lymphoma, Chronic Lymphocytic Leukemia, B Cell Malignancies, Non-Hodgkin's Lymphoma
AbbVie
Phase 1
78
Bankstown, Orange, Clayton, Melbourne
2023-04-04
Active, closed
Exelixis
Phase 3
901
Albury, Bankstown, Bedford Park, Heidelberg, Melbourne, Port Macquarie, Woodville South
2022-09-07
Recruiting
Cogent Biosciences, Inc.
Phase 3
482
Nedlands, Bankstown
2022-04-14
Recruiting
University of Melbourne
Phase 2/3
688
Bankstown, Newcastle, Sydney, Gold Coast, Woolloongabba, Adelaide, Melbourne, Murdoch
2021-11-29
Active, closed
Australian and New Zealand Intensive Care Research Centre
Phase 3
1,000
Bankstown, Camperdown, Kingswood, New Lambton Heights, Port Macquarie, Sydney, Tamworth, Westmead
2021-10-26
Recruiting
University of Sydney
Phase 3
445
Bankstown, Camperdown, Concord, Frenchs Forest, Liverpool, New Lambton Heights, Randwick, Wollongong
2021-10-14
Active, closed
Karyopharm Therapeutics Inc
Phase 3
353
Bankstown, Campbelltown, Liverpool, South Brisbane, Adelaide, Nedlands
2021-03-11
Recruiting
Population Health Research Institute
Phase 4
2,270
Garran, Bankstown, Camperdown, Concord, Liverpool, Newcastle, Westmead, Birtinya
2019-06-14
Recruiting
UMC Utrecht
Phase 3
20,000
Canberra, Bankstown, Blacktown, Campbelltown, Caringbah, Concord, Dubbo, Frenchs Forest
2016-04-11
Active, closed
University Hospitals of Derby and Burton NHS Foundation Trust
Not applicable
1,900
Adelaide, Bankstown, Brisbane, Coffs Harbour, Melbourne, Perth, Wagga Wagga
2014-08-01
Active, closed
Universitätsklinikum Hamburg-Eppendorf
Phase 3
789
Bankstown, Kingswood, Kogarah, Randwick, Waratah, Douglas, Herston, Woolloongabba
2014-04
Rows per page Showing 1–19 of 19
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Australian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 15 October 2026. https://priyalifescience.com/clinical-trials-australia/city/bankstown

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Australia and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 3,343 studies in total at the last sync on 15 Oct 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 19 of those studies with a site in Bankstown.

How many clinical trials are recruiting in Bankstown?

9 of the 19 studies on this page are recruiting new participants as of the 15 Oct 2026, 03:18 UTC sync. A further 0 have not yet opened recruitment, 10 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Bankstown), 19 studies
PhaseStudiesRecruitingShare
Phase 310452.6%
Phase 24221.1%
Phase 42210.5%
Not applicable105.3%
Phase 1105.3%
Phase 2/3115.3%

Most active sponsors

Lead sponsors with the most studies (Bankstown)
Lead sponsorStudiesRecruiting
AbbVie20
Taiho Oncology, Inc.22
AstraZeneca10
Australian and New Zealand Intensive Care Research Centre10
Cogent Biosciences, Inc.11
Coherus Oncology, Inc.10
Exelixis10
Karyopharm Therapeutics Inc10
Loxo Oncology, Inc.11
OncoC4, Inc.10
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.